Stock NVST ENVISTA HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Envista Holdings Corporation

Equities

NVST

US29415F1049

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 01:30:02 10/05/2024 am IST 		5-day change 1st Jan Change
19.28 USD +2.39% Intraday chart for Envista Holdings Corporation -2.68% -19.87%
01/05 Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Reports Q1 EPS $0.26, vs. Street Est of $0.32 MT
01/05 Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q1 Revenue $623.6M, vs. Street Est of $634.5M MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,702 5,385 7,271 5,490 4,124 3,236 - -
Enterprise Value (EV) 1 5,816 6,290 7,513 6,264 4,697 3,672 3,302 3,005
P/E ratio 18.5 x 169 x 23.5 x 24.6 x -40.1 x 24.7 x 18.5 x 17.9 x
Yield - - - - - - - -
Capitalization / Revenue 1.71 x 2.36 x 2.9 x 2.14 x 1.61 x 1.26 x 1.22 x 1.17 x
EV / Revenue 2.11 x 2.76 x 2.99 x 2.44 x 1.83 x 1.43 x 1.24 x 1.09 x
EV / EBITDA 13.8 x 20.8 x 15.2 x 12.1 x 10.1 x 9.4 x 7.65 x 6.39 x
EV / FCF 18.1 x 26.6 x 22.3 x 58.5 x 21.6 x 14.3 x 10.1 x 9.27 x
FCF Yield 5.52% 3.75% 4.48% 1.71% 4.63% 6.97% 9.92% 10.8%
Price to Book 1.33 x 1.45 x 1.79 x 1.31 x 0.99 x 0.74 x 0.7 x 0.66 x
Nbr of stocks (in thousands) 1,58,651 1,59,642 1,61,368 1,63,045 1,71,402 1,71,858 - -
Reference price 2 29.64 33.73 45.06 33.67 24.06 18.83 18.83 18.83
Announcement Date 30/01/20 10/02/21 09/02/22 08/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,752 2,282 2,509 2,569 2,566 2,572 2,663 2,767
EBITDA 1 420.7 303.1 495 517.4 464.2 390.7 431.5 470.1
EBIT 1 380.2 261.6 459.3 482.5 425.8 349.3 388.2 425.8
Operating Margin 13.82% 11.46% 18.31% 18.78% 16.59% 13.58% 14.58% 15.39%
Earnings before Tax (EBT) 1 275.5 -30.1 254.5 283.9 -54.9 200.2 289 248.3
Net income 1 217.6 33.3 340.5 243.1 -100.2 142 191.4 205.8
Net margin 7.91% 1.46% 13.57% 9.46% -3.9% 5.52% 7.19% 7.44%
EPS 2 1.600 0.2000 1.920 1.370 -0.6000 0.7626 1.016 1.053
Free Cash Flow 1 321.3 236.2 336.7 107 217.5 256 327.4 324
FCF margin 11.68% 10.35% 13.42% 4.16% 8.47% 9.95% 12.29% 11.71%
FCF Conversion (EBITDA) 76.37% 77.93% 68.02% 20.68% 46.85% 65.53% 75.87% 68.92%
FCF Conversion (Net income) 147.66% 709.31% 98.88% 44.01% - 180.3% 171.06% 157.42%
Dividend per Share 2 - - - - - - - -
Announcement Date 30/01/20 10/02/21 09/02/22 08/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 651.8 631.4 645.8 631.1 660.8 627.2 662.4 631.3 645.6 623.6 652 636.3 663.3 641.1 675.3
EBITDA 1 120.7 124.6 126.9 127.6 138.3 114 126.2 123.5 100.5 87.2 96.25 100 109.7 98.36 107.5
EBIT 1 110.7 116.5 118.3 119.5 128.2 105.2 116.6 114.4 89.6 77.6 85.95 89.04 99.69 87.66 97.58
Operating Margin 16.98% 18.45% 18.32% 18.94% 19.4% 16.77% 17.6% 18.12% 13.88% 12.44% 13.18% 13.99% 15.03% 13.67% 14.45%
Earnings before Tax (EBT) 1 37.2 85.9 59.1 63.2 75.7 55.7 68.6 35.8 -215 35.3 56.67 61.4 73.17 57.23 68.63
Net income 1 85.8 74.9 44.5 47.6 73.5 43.8 51.9 21.5 -217.4 23.6 41.03 43.01 50.88 41.26 48.79
Net margin 13.16% 11.86% 6.89% 7.54% 11.12% 6.98% 7.84% 3.41% -33.67% 3.78% 6.29% 6.76% 7.67% 6.43% 7.23%
EPS 2 0.4800 0.4200 0.2500 0.2700 0.4200 0.2500 0.2900 0.1200 -1.270 0.1400 0.1826 0.1942 0.2390 0.2362 0.2731
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 09/02/22 04/05/22 03/08/22 03/11/22 08/02/23 03/05/23 02/08/23 01/11/23 07/02/24 01/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,114 906 242 774 573 435 65.6 -
Net Cash position 1 - - - - - - - 232
Leverage (Debt/EBITDA) 2.647 x 2.988 x 0.4893 x 1.496 x 1.235 x 1.115 x 0.152 x -
Free Cash Flow 1 321 236 337 107 218 256 327 324
ROE (net income / shareholders' equity) 5.2% 4.44% 8.44% 8.36% 6.42% 4.65% 5.33% 6.13%
ROA (Net income/ Total Assets) 3.63% 0.51% 4.88% 5.25% 4.08% 2.63% 4.14% 4.5%
Assets 1 6,000 6,517 6,977 4,633 -2,455 5,393 4,627 4,575
Book Value Per Share 2 22.30 23.20 25.10 25.80 24.30 25.60 27.00 28.30
Cash Flow per Share 2 2.910 1.730 2.200 1.030 1.650 1.760 1.910 -
Capex 1 77.8 47.7 54.7 75.7 58.2 59.4 64.5 62
Capex / Sales 2.83% 2.09% 2.18% 2.95% 2.27% 2.31% 2.42% 2.24%
Announcement Date 30/01/20 10/02/21 09/02/22 08/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Envista Holdings Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
18.83 USD
Average target price
20.5 USD
Spread / Average Target
+8.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ENVISTA HOLDINGS CORPORATION Stock Envista Holdings Corporation
-19.87% 3.24B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.91% 183B
MEDTRONIC PLC Stock Medtronic plc
+0.46% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.62% 67.51B
DEXCOM, INC. Stock DexCom, Inc.
+3.26% 50.67B
CENCORA, INC. Stock Cencora, Inc.
+9.11% 44.7B
HOYA CORPORATION Stock Hoya Corporation
+3.26% 40.95B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+6.39% 26.8B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.83% 26.71B
TERUMO CORPORATION Stock Terumo Corporation
+14.60% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NVST Stock
  4. Financials Envista Holdings Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW